These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36426595)

  • 1. Reduced cerebral cortex thickness is related to overexpression of exosomal miR-146a-5p in medication-free patients with major depressive disorder.
    Deng Y; Gong P; Han S; Zhang J; Zhang S; Zhang B; Lin Y; Xu K; Wen G; Liu K
    Psychol Med; 2023 Oct; 53(13):6253-6260. PubMed ID: 36426595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant Expression of Intracellular let-7e, miR-146a, and miR-155 Correlates with Severity of Depression in Patients with Major Depressive Disorder and Is Ameliorated after Antidepressant Treatment.
    Hung YY; Wu MK; Tsai MC; Huang YL; Kang HY
    Cells; 2019 Jun; 8(7):. PubMed ID: 31252530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gray Matter Abnormalities in Non-comorbid Medication-naive Patients with Major Depressive Disorder or Social Anxiety Disorder.
    Zhao Y; Chen L; Zhang W; Xiao Y; Shah C; Zhu H; Yuan M; Sun H; Yue Q; Jia Z; Zhang W; Kuang W; Gong Q; Lui S
    EBioMedicine; 2017 Jul; 21():228-235. PubMed ID: 28633986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal miR-1202 mediates Brodmann Area 44 functional connectivity changes in medication-free patients with major depressive disorder: An fMRI study.
    Han S; Zheng Q; Zheng Z; Su J; Liu X; Shi C; Li B; Zhang X; Zhang M; Yu Q; Hou Z; Li T; Zhang B; Lin Y; Wen G; Deng Y; Liu K; Xu K
    J Affect Disord; 2024 Jul; 356():470-476. PubMed ID: 38608766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes from patients with major depression cause depressive-like behaviors in mice with involvement of miR-139-5p-regulated neurogenesis.
    Wei ZX; Xie GJ; Mao X; Zou XP; Liao YJ; Liu QS; Wang H; Cheng Y
    Neuropsychopharmacology; 2020 May; 45(6):1050-1058. PubMed ID: 31986519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical thickening in remitters compared to non-remitters with major depressive disorder following 8-week antidepressant treatment.
    Saricicek Aydogan A; Oztekin E; Esen ME; Dusmez S; Gelal F; Besiroğlu L; Zorlu N
    Acta Psychiatr Scand; 2019 Sep; 140(3):217-226. PubMed ID: 31250445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal let-7e, miR-21-5p, miR-145, miR-146a and miR-155 in Predicting Antidepressants Response in Patients with Major Depressive Disorder.
    Hung YY; Chou CK; Yang YC; Fu HC; Loh EW; Kang HY
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report.
    Suh JS; Minuzzi L; Raamana PR; Davis A; Hall GB; Harris J; Hassel S; Zamyadi M; Arnott SR; Alders GL; Sassi RB; Milev R; Lam RW; MacQueen GM; Strother SC; Kennedy SH; Frey BN
    Neuroimage Clin; 2020; 25():102178. PubMed ID: 32036277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group.
    Schmaal L; Hibar DP; Sämann PG; Hall GB; Baune BT; Jahanshad N; Cheung JW; van Erp TGM; Bos D; Ikram MA; Vernooij MW; Niessen WJ; Tiemeier H; Hofman A; Wittfeld K; Grabe HJ; Janowitz D; Bülow R; Selonke M; Völzke H; Grotegerd D; Dannlowski U; Arolt V; Opel N; Heindel W; Kugel H; Hoehn D; Czisch M; Couvy-Duchesne B; Rentería ME; Strike LT; Wright MJ; Mills NT; de Zubicaray GI; McMahon KL; Medland SE; Martin NG; Gillespie NA; Goya-Maldonado R; Gruber O; Krämer B; Hatton SN; Lagopoulos J; Hickie IB; Frodl T; Carballedo A; Frey EM; van Velzen LS; Penninx BWJH; van Tol MJ; van der Wee NJ; Davey CG; Harrison BJ; Mwangi B; Cao B; Soares JC; Veer IM; Walter H; Schoepf D; Zurowski B; Konrad C; Schramm E; Normann C; Schnell K; Sacchet MD; Gotlib IH; MacQueen GM; Godlewska BR; Nickson T; McIntosh AM; Papmeyer M; Whalley HC; Hall J; Sussmann JE; Li M; Walter M; Aftanas L; Brack I; Bokhan NA; Thompson PM; Veltman DJ
    Mol Psychiatry; 2017 Jun; 22(6):900-909. PubMed ID: 27137745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
    Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
    Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased cortical thickness of left premotor cortex as a treatment predictor in major depressive disorder.
    Liu X; Hou Z; Yin Y; Xie C; Zhang H; Zhang H; Zhang Z; Yuan Y
    Brain Imaging Behav; 2021 Jun; 15(3):1420-1426. PubMed ID: 32710337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Brain Cortical Changes With Relapse in Patients With Major Depressive Disorder.
    Zaremba D; Dohm K; Redlich R; Grotegerd D; Strojny R; Meinert S; Bürger C; Enneking V; Förster K; Repple J; Opel N; Baune BT; Zwitserlood P; Heindel W; Arolt V; Kugel H; Dannlowski U
    JAMA Psychiatry; 2018 May; 75(5):484-492. PubMed ID: 29590315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglia secrete miR-146a-5p-containing exosomes to regulate neurogenesis in depression.
    Fan C; Li Y; Lan T; Wang W; Long Y; Yu SY
    Mol Ther; 2022 Mar; 30(3):1300-1314. PubMed ID: 34768001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of cortical thickness abnormalities in medication-free patients with major depressive disorder.
    Li Q; Zhao Y; Chen Z; Long J; Dai J; Huang X; Lui S; Radua J; Vieta E; Kemp GJ; Sweeney JA; Li F; Gong Q
    Neuropsychopharmacology; 2020 Mar; 45(4):703-712. PubMed ID: 31694045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Prospective, Longitudinal Study of the Effect of Remission on Cortical Thickness and Hippocampal Volume in Patients with Treatment-Resistant Depression.
    Phillips JL; Batten LA; Tremblay P; Aldosary F; Blier P
    Int J Neuropsychopharmacol; 2015 Mar; 18(8):. PubMed ID: 25829180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional cortical thinning in patients with major depressive disorder: a surface-based morphometry study.
    Tu PC; Chen LF; Hsieh JC; Bai YM; Li CT; Su TP
    Psychiatry Res; 2012 Jun; 202(3):206-13. PubMed ID: 22521631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of inflammation markers on cortical thinning in major depressive disorder: A possible mediator of depression and cortical changes.
    Kang Y; Shin D; Kim A; You SH; Kim B; Han KM; Ham BJ
    J Affect Disord; 2024 Mar; 348():229-237. PubMed ID: 38160887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-derived neurotrophic factor Val66Met polymorphism affects cortical thickness of rostral anterior cingulate in patients with major depressive disorder.
    Shen Z; Lu Y; Jiang H; Ye J; Zhou C; He M; Li N; Xu X; Cheng Y
    Neuroreport; 2020 Nov; 31(16):1146-1153. PubMed ID: 32991522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Widespread reductions in gray matter volume in depression.
    Grieve SM; Korgaonkar MS; Koslow SH; Gordon E; Williams LM
    Neuroimage Clin; 2013; 3():332-9. PubMed ID: 24273717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cigarette smoking on cortical thickness in major depressive disorder.
    Zorlu N; Cropley VL; Zorlu PK; Delibas DH; Adibelli ZH; Baskin EP; Esen ÖS; Bora E; Pantelis C
    J Psychiatr Res; 2017 Jan; 84():1-8. PubMed ID: 27669406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.